Analgesic, antioxidant and anti-inflammatory related activities of 21-hydroxy-2,41-dimethoxychalcone and 4-hydroxychalcone in mice

Journal of Biological Sciences

Volumn 8, Issue 1, 2008, Pages 131-136

  Oyedapo, O A ^a   Adewunmi, C O ^a   Iwalewa, E O ^a   Makanju, V O ^a  

^a OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

Author keywords

21 hydroxy 2; 4 hydroxychalcone; 41 dimethoxychalcone; Analgesic; Anti inflammatory activities; Antioxidant; Chalcones

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 2 HYDROXY 2,4 DIMETHOXYCHALCONE; 4 HYDROXYCHALCONE; ACETIC ACID; ACETYLSALICYLIC ACID; ASCORBIC ACID; CHALCONE DERIVATIVE; INDOMETACIN; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; HOT PLATE TEST; LEUKOCYTE COUNT; LUNG EDEMA; MALE; MOUSE; NONHUMAN; PAIN THRESHOLD; PAW EDEMA; PLEURISY;

MUS;

EID: 42449083293     PISSN: 17273048     EISSN: 18125719     Source Type: Journal    
DOI: 10.3923/jbs.2008.131.136     Document Type: Article

References (32)

1. Adewunmi, C.O., F.O. Ogungbamila and J.O. Oluwadiya, 1987. Molluscicidal activities of some synthetic chalcones, Planta Med., 53: 110-112.
2. Alcaraz, M.J. and M.J. Jimenez, 1988. Flavonoids as anti-inflammatory agents. Fitoterapia LIX: 25-38.
3. Ames, B.N., M.K. Shigenaga and T.M. Hagen, 1993. Oxidants, antioxidants and the degenerative diseases of aging Proceedings of Nat. Acad. Sci., 90: 7915-7922.
4. Anto, R.J., K. Sukumaran, G. Kuttan, M.N.A. Rao, V. Subbaraju and R. Kuttan, 1995 Anticancer and antioxidant activity of synthetic chalcones and related compounds. Cancer Lett., 97: 33-37.
5. Batt, D.G., R. Goodman, D.G. Jones, J.S. Kerr, L.R. Mantegna, C. Macallister, R.C. Newton, S. Nurnberg, P.K. Welch and M.B. Covington, 1993. 2′-Substituted chalcone derivatives inhibitor of Interleukin-1 biosynthesis. J. Med. Chem., 36: 1434-1442.
6. Calliste, C.A, J.C. Le Bail, P. Trouillas, C. Pouget, G. Habrioux, A.J. Chulia and J.L. Duroux, 2001. Chalcones: structural requirements for antioxidant, estrogenic and antiproliferative activities. Anticancer Res., 21: 3949-3956.
7. Cohn, M.A., S.S. Frankel, S. Rugpao, M.A. Young and G. Willet et al., 2001. Chronic inflammation with increased Human Immunodeficiency Virus (HIV) RNA expression in the vaginal epithelium of HIV-infected Thai women. J. Infect. Dis., 184: 410-417.
8. Devia, C.M., N.B. Pappano and N.B. Debattista, 1998. Structure-Biological Acitivity Relationship of synthetic trihydroxilated Chalcones. Rev. Microbiolo., 29: 307-310.
9. Gabor, M., 1979. In: Handbook of Experimental Pharmacology: Anti-inflammatory Drugs. Vane J.R. and S.H. Ferreira (Eds.), Springer, New York, pp: 698-710.
10. Haraguchi, H., H. Ishikawa, K. Mizutani, Y. Tamura and T. Kinoshita, 1998. Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflata. Bioorg. Med. Chem., 6: 339-347.
11. Hayashi, K., T. Nagamatsu, S. Honda and Y. Suzuki, 1996. Butein (3,4,2′,4′-tetrahydroxychalcone) ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis. Eur. J. Pharmacol., 316: 297-306.
12. Hsieh, H.K, T.H. Lee, J.P. Wang, J.I. Wang and C.N. Lin, 1998. Synthesis and anti-inflammatory effect of chalcones and related compounds. Pharm. Res., 15: 39-46.
13. Koster, R., M. Anderson and E.J. De-Beer, 1959. Acetic acid for analgesic screening. Fed. Pro., 18: 412-418.
14. Lian, X., C. Yan, L. Yang, Y. Xu and H. Du, 2004. Lysosomal acid lipase deficiency causes respiratory inflammation and destruction in the lung. Am. J. Physiol. Lung Cell. Mol. Physiol., 286: L801-L807.
15. Lin, C.N., T.H. Lee, M.F. Hsu, J.P. Wang, F.N. Ko and C.M. Teng, 1997. 2′,5′-dihydroxychalcone as a potent chemical mediator and cyclooxygenase inhibitor. J. Pharm. Pharmacol., 49: 530-536.
16. Liu, M., P. Wilairat and M.L. Go, 2001. Antimalarial alkoxylated and hydroxylated chalcones [corrected]: Structure-activity relationship analysis. J. Med. Chem., 44: 4443-4452.
17. Machala, M., R. Kubinova, P. Horavova and V. Suchy, 2001. Chemoprotective potentials of homoisoflavonoids and chalcones of Dracaena cinnabari: Modulations of drug-metabolizing enzymes and antioxidant activity. Phytother. Res., 15: 114-118.
18. Madan, B., S. Batra and B. Ghosh, 2000. 2′-Hydroxychalcone inhibits nuclear factor-KB and blocks tumor necrosis factor-α-and lipopolysaccharide-induced adhesion of neutrophils to human umbilical vein endothelial cells. Mol. Pharmacol., 58: 526-534.
19. Makita, H., T. Tanaka, H. Fujitsuka, N. Tatematsu, K. Satoh, A. Hara and H. Mori, 1996. Chemoprevention of 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis by the dietary flavonoids chalcone, 2-hydroxychalcone and quercetin. Cancer Res., 56: 4904-4909.
20. Oguchi, S., P. Dimayuga, J. Zhu, K-Y. Chyu, J. Yano, P.K. Shah, J. Nilsson and B. Cercek, 2000. Monoclonal antibody against vascular cell adhesion molecule-1 inhibits neointimal formation after periadventitial carotid artery injury in genetically hypercholesterolemic Mice Arterioscler. Thromb. Vasc. Biol., 20: 1729-1736.
21. Opletalová, V., P. Øièièáøová, D. Šedivý, D. Meltrová and J. Køiváková, 2000. Chalcones and their Heterocyclic Analogues as Potential Medicaments Folia Pharmaceutica Universitatis Carolinae., 25: 21-33.
22. Oyedapo, O.A., C.O. Adewunmi, V.O. Makanju, T.K. Adenowo and E.O. Iwalewa, 2004. Antitrichomonal activities of synthetic 1,3-diaryl-2-propen-1-ones on Trichomonas gallinae. Afr. J. Trad. Compl. Alter. Med., 1: 55-62.
23. Parimaladevi, B., R. Boominathan and S.C. Mandal, 2003. Studies on analgesic activity of Cleome viscosa in mice. Fitoterapia, 74: 262-266.3.
24. Rang, H.P., M.M. Dale and J.M. Ritter, 1998. Pharmacology 3rd Edn., Churchill Livingstone London, pp: 214-245.
25. Repetto, M.G. and S.F. Llesuy, 2002. Antioxidant properties of natural compounds used in popular medicine for gastric ulcers. Braz. J. Med. Biol. Res., 35: 523-534.
26. Sanchez-Moreno, C., J.A. Larrauri and F. Saura-Calixto, 1998. A procedure to measure the antiradical efficiency of polyphenols. J. Sci. Food Agric., 76: 270-276.
27. Staub, N.C., 1974. Pulmonary oedema. Physiol. Rev., 54: 698-811.
28. Subramoniam, A., D.A. Evans, S. Rajasekharan and G. Sreekandan-Nair, 2001. Effect of Hemigraphis colorata (Blume) leaf on wound healing and inflammation in mice. Ind. J. Pharmacol., 33: 283-285.
29. Vadas. P., J. Keystone, E. Stefanski, K. Scott and W. Pruzanski, 1992. Induction of circulating group II phospholipase. A2 expression in adults with malaria Infect. Immunol., 60: 3928-3931.
30. Vinegar, R., J.F. Truax, J.L. Selph and F.A. Voelker, 1982. Pathway of onset, development and decay of carrageenan pleurisy in the Rat. Fed. Pro., 41: 2588-2595.
31. Xu, H., J.A. Gonzalo, Y.S. Pierre, I.R. Williams T.S. Kupper, R.S. Cotran, T.A. Springer, J. Carlos and G. Ramos, 1994 Leukocytosis and resistance to septic shock in intercellular adhesion molecule1-defecient mice. J. Exp. Med., 180: 95-101.
32. Yu, S.M., Z.J. Cheng and S.C. Kuo, 1995. Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor. Eur. J. Pharmacol., 280: 69-77.